GlassScriptPhysician profile
Stephanie Guice
NPI 1992187223
$1,108.11
in general payments reported to CMS, 2019-2025
19 companies · $472 in 2025
The $472 reported for 2025 was more than what 91% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $121 · 2023: $50.15 · 2024: $465 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $986.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $321.92 | 2024-2025 | |
| Alkermes, INC. | $121.47 | 2022 | |
| Janssen Pharmaceuticals, INC | $89.02 | 2025 | Spravato |
| Otsuka America Pharmaceutical, INC. | $76.79 | 2024-2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $55.90 | 2024-2025 | Qelbree |
| Axsome Therapeutics, INC. | $55.57 | 2024-2025 | Auvelity |
| Sanofi-Aventis U.S. LLC | $51.69 | 2024 | |
| Corium, LLC | $48.77 | 2024 | Azstarys |
| Collegium Pharmaceutical, INC. | $43.61 | 2025 | Jornay Pm |
| Vanda Pharmaceuticals INC. | $35.17 | 2025 | Fanapt |
| Merck Sharp & Dohme LLC | $33.39 | 2024-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Takeda Pharmaceuticals U.S.A., INC. | $32.99 | 2025 | Trintellix |
| Lundbeck LLC | $29.42 | 2025 | Rexulti |
| Sanofi Pasteur INC. | $26.15 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.35 | 2025 | Caplyta |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $19.15 | 2023 | Quviviq |
| Hologic Sales and Service, LLC | $15.50 | 2023 | Aptima |
| Novo Nordisk INC | $15.50 | 2023 | Wegovy |
| Teva Pharmaceuticals USA, INC. | $14.75 | 2025 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Guice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.